All roads lead to NF-κB: the NF-κB pathway as a major target for intestinal inflammatory disorders

Rasul Khasanov, Michael Boettcher, Lucas M. Wessel, Karl-Herbert Schäfer, María Ángeles Tapia-Laliena · 2026

Read All roads lead to NF-κB: the NF-κB pathway as a major target for intestinal inflammatory disorders by Rasul Khasanov, Michael Boettcher, Lucas M. Wessel, Karl-Herbert Schäfer, María Ángeles Tapia-Laliena (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171789.txt.

Description

Rasul Khasanov and four co-authors review a master switch of inflammation as a drug target for gut disorders, in a 2026 paper. The switch, a family of proteins called NF-κB, controls genes for immune responses. In the intestine it reacts to shifts in gut microbes and to bacterial toxins, driving cytokine release, immune cell recruitment, and antibody production.

When the switch is overactive, the gut barrier leaks and inflammation can spread to distant organs, even the brain. The review ties this pathway to Crohn's disease, ulcerative colitis, celiac disease, irritable bowel syndrome, and a severe newborn gut condition, among others. It also covers neutrophil traps that further stir the pathway. Blocking the switch with drugs, peptides, or natural compounds eased symptoms in many preclinical settings. The authors weigh current and emerging strategies for targeting it.

Catalog record

CREATORRasul Khasanov, Michael Boettcher, Lucas M. Wessel, Karl-Herbert Schäfer, María Ángeles Tapia-Laliena
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13171789

Browse the full library · About the Tower of Babel